FLUTICASONE PROPIONATE INHALER HFA

The Defense Logistics Agency awarded a delivery order under basic contract SPE2DX-25-D-9900 to DMS Pharmaceutical Group Inc. with CAGE code 1UNB0 for the supply of 30,000 units of FLUTICASONE PROPIONATE INHALER HFA, identified by NSN 6505015326924, at a total contract value of $3,366.30. The award was made on July 14, 2026, with delivery due by July 29, 2026, to Fort Bragg, North Carolina, under FOB destination terms, meaning the contractor assumes all transportation costs and risks until the goods are delivered and accepted at the destination. The unit price is $0.11221 per inhaler, with zero variance permitted in quantity, and the contract is a single-line, fixed-price, non-optioned delivery order. Payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, using accounting code BX: 97X4930 5CBX 001 2620 S33189 and payment code SL4701. The awardee is certified as a Small Business and a Women-Owned Small Business, triggering compliance obligations under FAR Part 19 and the WOSB Federal Contract Program. Packaging and marking must include the CAGE code, part number, NDC, and DO counter, with traceable shipping required and parcel post prohibited; no specific MIL-STD or bar-coding standards are mandated. Inspection and acceptance occur at the delivery point by the government, with no independent quality or technical specifications cited beyond general compliance with medical supply standards and the terms of the underlying basic contract. The contracting officer is Lisa Quinn, and administrative contact is Shairy M. Cartagena, though no COR or COTR is formally designated. The procurement was awarded based on lowest price, consistent with LPTA criteria, and no special requirements, security clearances, key personnel, or option periods are included. No attachments, evaluation factors, or detailed clauses are enumerated, indicating reliance on the basic contract and standard DLA procedures.